Increasing access to medications for opioid use disorder in residential treatment centers
Official title: Scaling-up Medication for Opioid Use Disorder in Residential Treatment Settings
Funded at Rutgers Biomedical and Health Sciences · NIH-11061403 · Data updated 2026-11-12
This study is looking at ways to make it easier for residential treatment programs to use medications like methadone and buprenorphine to help people with opioid use disorder, especially those at risk of overdose after they leave treatment, so that they can get better support during their recovery.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | April 1, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $236,088 |
| NIH project number | 5K99DA057372-02 |
| Project ID | NIH-11061403 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with opioid use disorder who are receiving or have recently completed treatment in residential programs.
✕Less likely to help
Patients who are not struggling with opioid use disorder or those who are not engaged in residential treatment programs may not benefit from this research.
What this research studies
This research investigates how to improve the use of medications for opioid use disorder (MOUD) like methadone and buprenorphine in residential treatment programs. It aims to identify the factors that can help these programs adopt MOUD more effectively, especially for individuals who are at high risk of overdose after leaving treatment. By analyzing data and implementing new strategies, the research seeks to enhance the support for patients during their recovery journey. The study is particularly focused on Medicaid beneficiaries who are vulnerable to opioid use disorder.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of overdose and improve recovery outcomes for individuals with opioid use disorder.
How similar studies have gone: Previous research has shown that increasing access to medications for opioid use disorder can lead to better treatment outcomes, indicating that this approach has potential for success.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Miles, Jennifer — Rutgers Biomedical and Health Sciences
- Study coordinator: Miles, Jennifer
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.